-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$70.1155.14% Upside
Recent Analyst Forecasts and Stock Ratings
RxSight, Inc. Frequently Asked Questions
-
What analysts cover RxSight, Inc.?
RxSight, Inc. has been rated by research analysts at Barclays, Mizuho Securities, Guggenheim, Jefferies, BTIG, Needham in the past 90 days.